H.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)
26 July 2022 - 08:17PM
TipRanks
H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on
Angion Biomedica (ANGN – Research Report) today. The company's
shares closed last Monday at $0.99, close to its 52-week low of
$0.98. According to TipRanks.com, Selvaraju is ranked 0 out of 5
stars with an average return of -37.8% and a 18.0% success rate.
Selvaraju covers the Healthcare sector, focusing on stocks such as
Santhera Pharmaceuticals Holding AG, MoonLake Immunotherapeutics,
and Timber Pharmaceuticals. Currently, the analyst consensus on
Angion Biomedica is a Hold with an average price target of
$1.50.
https://www.tipranks.com/news/blurbs/h-c-wainwright-reiterates-their-hold-rating-on-angion-biomedica-angn?utm_source=advfn.com&utm_medium=referral
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Oct 2023 to Dec 2023
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Dec 2022 to Dec 2023
